Shanghai, China

Zhiqiang Dong

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Impact Therapeutics (Shanghai), Inc, Shanghai Litedd Co., Ltd.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhiqiang Dong. Retrieved from https://idiyas.com/inventor/zhiqiang-dong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhiqiang Dong: Innovator in Pharmaceutical Compounds

Introduction

Zhiqiang Dong is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work has implications for treating diseases associated with abnormal cellular activities.

Latest Patents

Zhiqiang Dong holds a patent for "Imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6H)-ones and the use thereof." This patent discloses imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6H)-one compounds, specifically represented by a defined formula. These compounds act as Wee1 kinase inhibitors, which may be utilized in treating diseases caused by abnormal Wee1 activity. He has 1 patent to his name.

Career Highlights

Throughout his career, Zhiqiang Dong has worked with various companies, including Impact Therapeutics (Shanghai) Inc. and Littdd Medicines Ltd. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in the pharmaceutical industry.

Collaborations

Zhiqiang Dong has collaborated with notable colleagues such as Suixiong Cai and Ye Edward Tian. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic compounds.

Conclusion

Zhiqiang Dong's contributions to pharmaceutical innovations highlight his role as a key inventor in the field. His work on Wee1 kinase inhibitors demonstrates the potential for new treatments in addressing critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…